Dimitris Polygenis - McKesson Canada

Dimitris Polygenis
President, McKesson Canada
As President of McKesson Canada, Dimitris is responsible for leading McKesson’s portfolio of businesses in Canada including pharmaceutical distribution operations, Specialty Health, and McKesson’s network of independent pharmacies comprised of I.D.A., Guardian, Remedy’sRx, The Medicine Shoppe, Uniprix, and Proxim.
Dimitris joined McKesson Canada in 2005 following the acquisition of Phase 4 Health, a specialty and manufacturer-facing services company he helped build and grow. This acquisition resulted in the creation of McKesson Specialty Health, which offers a comprehensive range of services to manufacturers. Under his leadership, the group expanded to become Canada’s largest specialty services provider.
Over the past two decades, Dimitris has held executive leadership roles across every operational business unit within the Canadian portfolio, driving transformational growth across the organization. He is recognized as a strategic business leader committed to customer success, operational excellence, and building high-performing teams.
Dimitris holds a Doctor of Pharmacy from the University of Toronto and has served on several boards in the healthcare industry including positions at the University of Toronto, University of British Columbia Pharmacy Programs and the Canadian Association for Pharmacy Distribution Management (CAPDM) as Chair. He is a current board member of the Neighbourhood Pharmacy Association of Canada (NPAC) and the Canadian Pharmacists Association (CPhA), where he chairs the National Pharmacy Business Council.

Dimitris Polygenis
President, McKesson Canada
As President of McKesson Canada, Dimitris is responsible for leading McKesson’s portfolio of businesses in Canada including pharmaceutical distribution operations, Specialty Health, and McKesson’s network of independent pharmacies comprised of I.D.A., Guardian, Remedy’sRx, The Medicine Shoppe, Uniprix, and Proxim.
Dimitris joined McKesson Canada in 2005 following the acquisition of Phase 4 Health, a specialty and manufacturer-facing services company he helped build and grow. This acquisition resulted in the creation of McKesson Specialty Health, which offers a comprehensive range of services to manufacturers. Under his leadership, the group expanded to become Canada’s largest specialty services provider.
Over the past two decades, Dimitris has held executive leadership roles across every operational business unit within the Canadian portfolio, driving transformational growth across the organization. He is recognized as a strategic business leader committed to customer success, operational excellence, and building high-performing teams.
Dimitris holds a Doctor of Pharmacy from the University of Toronto and has served on several boards in the healthcare industry including positions at the University of Toronto, University of British Columbia Pharmacy Programs and the Canadian Association for Pharmacy Distribution Management (CAPDM) as Chair. He is a current board member of the Neighbourhood Pharmacy Association of Canada (NPAC) and the Canadian Pharmacists Association (CPhA), where he chairs the National Pharmacy Business Council.